Caterna offers a digital therapy for children with amblyopia, allowing treatment at home through specific online games designed to stimulate eye function. The product is a medically certified treatment developed at TU Dresden.

Caterna

Nia Health develops medical software based on its MedTech platform for personalized patient support, offering end-to-end solutions in dermatology and allergology. Their Digital Therapeutics solutions utilize clinical validation, gamification, and machine learning to enhance patient engagement.

Nia Health

Dopavision develops a technology called MyopiaX® aimed at slowing the progression of myopia in children and adolescents through selective ocular light stimulation. The company focuses on addressing a public health issue related to myopia.

Dopavision

Caterna Vision GmbH | 404 followers on LinkedIn. A digital therapy platform for chronic eye conditions
 | Caterna Vision is a digital therapy platform for chronic eye conditions like amblyopia and dry AMD and allows patients a state-of-the-art treatment from the comfort of their home.

Klaus Stöckemann

expert & entrepreneur

Sascha Seewald

Co-Founder bei Caterna

Johannes Rösler

VC Investor - Life Sciences & Health

Nam Nhito

Caterna Vision GmbH

DOG Berlin 2024 bietet immer wieder Gelegenheit zum spontanen Austausch zwischen Opthalmo-Startups

#amblyopie , #augenpflaster , #motivation , #therapieadhärenz

Caterna ist eines der deutschen Unternehmen, dass mit der deutschen Biopharma Delegation in Peking, Shanghai und Hainan auf der Suche nach potentiellen Kooperationspartnern ist.

Präsentation von Caterna Vision bei La French Tech Munich . Vielen Dank an Estefanía 'Nia' Escobar-Kölle für den interaktiven Workshop zum Markteintritt Frankreich.

Wir sind jetzt ein MDR-zertifiziertes Medizinprodukt der Klasse 1

Seitdem wurden über 4.500 Patienten behandelt und können ein besseres Leben durch besseres Sehen führen. Dr. Markus Müschenich, MPH Ursula Hahn

Caterna Vision ist bei der größten health.tech conference mit dabei 📣

Wir sind beim EIC Accelerator des Horizon Europe Program mit unserem Antrag "Focal Ambient Visual Acuity Stimulation (FAVAS) bei trockener AMD" eine Runde weiter und werden hoffentlich bald zu den Interviews eingeladen.

Vielen Dank an die Augenklinik Petrisberg und das Knappschaftsklinikum Saar für die Unterstützung bei der Amblyopie-Studie.

Metric
Company Name	Caterna	Nia Health	Dopavision
Symbol
MSH ID	DE:CATERNA	AI:NIAHEALTH	COM:DOPAVISION
Market	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services
Industry	Digital Health	Medical Device and Software Development	Medical Technology
Country	DE	DE	DE
Stage
Employee Count
Website	caterna.de	niahealth.ai	dopavision.com
LinkedIn	caterna		dopavision
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

CATE

DE:CATERNA

Caterna

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue